# Tofacitinib or Adalimumab versus Placebo in Rheumatoid Arthritis

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/tofacitinib-or-adalimumab-versus-placebo-in-rheumatoid-arthritis/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Ronald van Vollenhoven,Roy Fleischmann,Stanley Cohen,Eun Bong Lee,Juan A. García Meijide,Sylke Wagner,Šárka Forejtová,Samuel H. Zwillich,David Gruben,Tamás Koncz,Gene V. Wallenstein,Sriram Krishnaswami,John Bradley,Bethanie Wilkinson |
| Citations | 944 |
| DOI | 10.1056/nejmoa1112072 |
| Fields | Medicine |
| Open Access | true |
| OA Status | bronze |
| OA URL | https://www.nejm.org/doi/pdf/10.1056/NEJMoa1112072?articleTools=true |
| OpenAlex ID | https://openalex.org/W2069302785 |
| PMID | 22873531 |
| Type | article |
| Year | 2012 |

## Paper authors

- [Ronald van Vollenhoven](https://scholariq.org/researchers/ronald-van-vollenhoven/)
- [David Gruben](https://scholariq.org/researchers/david-gruben/)

## Paper journal

- [New England Journal of Medicine](https://scholariq.org/journals/new-england-journal-of-medicine/)

## Paper primary topic

- [Rheumatoid Arthritis Research and Therapies](https://scholariq.org/topics/rheumatoid-arthritis-research-and-therapies/)

## Paper topics

- [Rheumatoid Arthritis Research and Therapies](https://scholariq.org/topics/rheumatoid-arthritis-research-and-therapies/)
- [Spondyloarthritis Studies and Treatments](https://scholariq.org/topics/spondyloarthritis-studies-and-treatments/)
- [Autoimmune and Inflammatory Disorders Research](https://scholariq.org/topics/autoimmune-and-inflammatory-disorders-research/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.